Skip to main content
. 2019 Jul 22;9:10588. doi: 10.1038/s41598-019-46745-0

Figure 2.

Figure 2

PCSK9 function is negatively correlated with the uptake of lipoteichoic acid by hepatocytes. (A) HepG2 hepatocytes were pre-treated with various concentrations of recombinant wildtype PCSK9 two hours before the treatment of the fluorescently labeled LTA (BODIPY-FL-LTA, 1 μg/mL). After 24 hours of LTA treatment, cells were analyzed by flow cytometry. Mean fluorescence intensity were normalized to cells without PCSK9 treatment. (B) Same as experiment as in (A) but HepG2 hepatocytes were treated with 3 different PCSK9 LOF variants, rs11583680, rs11591147 and rs562556. Results are shown as percent change in LTA uptake as compared cells treated with wildtype PCSK9 at the same concentration. Error bars are Standard Deviations; n = 3 experiments per data point.